Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.

Source:http://linkedlifedata.com/resource/pubmed/id/7674333

J. Natl. Cancer Inst. 1995 Oct 4 87 19 1463-9

Download in:

View as

General Info

PMID
7674333